Kovitz Investment Group Partners LLC lifted its stake in Agilent Technologies, Inc. (NYSE:A – Get Rating) by 59.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 11,485 shares of the medical research company’s stock after buying an additional 4,295 shares during the period. Kovitz Investment Group Partners LLC’s holdings in Agilent Technologies were worth $1,361,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in A. Alphastar Capital Management LLC acquired a new stake in Agilent Technologies in the 4th quarter valued at about $407,000. Kentucky Retirement Systems Insurance Trust Fund grew its position in shares of Agilent Technologies by 1.3% during the 4th quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 8,200 shares of the medical research company’s stock worth $1,309,000 after buying an additional 105 shares during the period. Kentucky Retirement Systems grew its position in shares of Agilent Technologies by 3.4% during the 4th quarter. Kentucky Retirement Systems now owns 18,725 shares of the medical research company’s stock worth $2,989,000 after buying an additional 615 shares during the period. Advisory Alpha LLC grew its position in shares of Agilent Technologies by 21.0% during the 4th quarter. Advisory Alpha LLC now owns 2,311 shares of the medical research company’s stock worth $369,000 after buying an additional 401 shares during the period. Finally, Toronto Dominion Bank grew its position in shares of Agilent Technologies by 7.7% during the 4th quarter. Toronto Dominion Bank now owns 179,111 shares of the medical research company’s stock worth $28,595,000 after buying an additional 12,849 shares during the period.
In other news, SVP Michael Tang sold 1,210 shares of the firm’s stock in a transaction that occurred on Friday, March 18th. The shares were sold at an average price of $136.21, for a total transaction of $164,814.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
Agilent Technologies (NYSE:A – Get Rating) last released its quarterly earnings results on Tuesday, February 22nd. The medical research company reported $1.21 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.17 by $0.04. Agilent Technologies had a net margin of 18.70% and a return on equity of 27.04%. The business had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.66 billion. During the same period in the prior year, the company posted $1.06 earnings per share. Agilent Technologies’s revenue was up 8.1% compared to the same quarter last year. Analysts predict that Agilent Technologies, Inc. will post 4.86 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 27th. Investors of record on Tuesday, April 5th will be issued a $0.21 dividend. The ex-dividend date of this dividend is Monday, April 4th. This represents a $0.84 dividend on an annualized basis and a yield of 0.67%. Agilent Technologies’s dividend payout ratio (DPR) is presently 21.32%.
Several equities research analysts have recently commented on A shares. Bank of America lowered their price target on shares of Agilent Technologies from $179.00 to $160.00 and set a “buy” rating for the company in a research report on Wednesday, February 23rd. Evercore ISI decreased their price objective on shares of Agilent Technologies from $170.00 to $155.00 and set an “outperform” rating for the company in a report on Wednesday, February 23rd. Stifel Nicolaus decreased their price objective on shares of Agilent Technologies from $169.00 to $145.00 and set a “hold” rating for the company in a report on Wednesday, February 23rd. StockNews.com assumed coverage on shares of Agilent Technologies in a report on Thursday, March 31st. They set a “strong-buy” rating for the company. Finally, SVB Leerink decreased their price objective on shares of Agilent Technologies from $175.00 to $145.00 and set an “outperform” rating for the company in a report on Wednesday, February 23rd. Two investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Buy” and an average price target of $160.54.
Agilent Technologies Company Profile (Get Rating)
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.
- Get a free copy of the StockNews.com research report on Agilent Technologies (A)
- Workhorse Johnson & Johnson Plows New All-Time Highs
- Fastenal Stock is Ready to Sprint Higher
- J.B. Hunt Transportation Services Fires On All Cylinders
- 3 No-Brainer Stocks to Buy with $1000
- Rite Aid Stock is Getting Cheap Enough to Buy Here
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.